Using Low-Power, Low-Cost IoT Processors in Clinical Biosignal Research: an In-depth Feasibility Check.

Research on biosignal (ExG) analysis is usually performed with expensive systems requiring connection with external computers for data processing. Consumer-grade low-cost wearable systems for bio-potential monitoring and embedded processing have been presented recently, but are not considered suitable for medical-grade analyses. This work presents a detailed quantitative comparative analysis of a recently presented fully-wearable low-power and low-cost platform (BioWolf) for ExG acquisition and embedded processing with two researchgrade acquisition systems, namely, ANTNeuro (EEG) and the Noraxon DTS (EMG). Our preliminary results demonstrate that BioWolf offers competitive performance in terms of electrical properties and classification accuracy. This paper also highlights distinctive features of BioWolf, such as real-time embedded processing, improved wearability, and energy-efficiency, which allows devising new types of experiments and usage scenarios for medical-grade biosignal processing in research and future clinical studies.